Initial Statement of Beneficial Ownership (Form 3)

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Mathew Marlyn Teresa 2. Date of Event Requiring Statement (Month/Day/Year) 04/17/2026 3. Issuer Name and Ticker or Trading Symbol Zura Bio Ltd [ZURA] (Last) (First) (Middle) C/O ZURA BIO LTD, 1489 W. WARM SPRINGS RD. #110 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) VP, Principal Acctg. Officer 5. If Amendment, Date Original Filed (Month/Day/Year) (Street) HENDERSON, NV 89014 6. Individual or Joint/Group Filing (Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Class A Ordinary Shares 129,182(1) D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Share Option (Right to Buy)	(2)	06/08/2032	Class A Ordinary Shares	37,505	(3)	D
Employee Share Option (Right to Buy)	(4)	03/15/2033	Class A Ordinary Shares	11,133	(5)	D
Employee Share Option (Right to Buy)	(6)	06/18/2034	Class A Ordinary Shares	90,000	$3.38	D
Employee Share Option (Right to Buy)	(7)	02/27/2035	Class A Ordinary Shares	81,150	$1.2	D
Employee Share Option (Right to Buy)	(8)	04/01/2036	Class A Ordinary Shares	66,220	$6.03	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Mathew Marlyn Teresa C/O ZURA BIO LTD 1489 W. WARM SPRINGS RD. #110 HENDERSON, NV 89014			VP, Principal Acctg. Officer

Signatures

/s/ Kim Davis, Attorney-in-Fact		06/22/2026
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Includes 32,296 shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs shall vest in full on May 18, 2027, subject to the Reporting Person's continuous service through such vesting date.
(2)	Immediately exercisable.
(3)	$0.83732
(4)	One fourth (1/4) of the shares subject to the option award vested on March 15, 2024 and the remaining shares subject to the option vested or shall vest in thirty-six (36) monthly installments thereafter on the last day of the month, subject to the Reporting Person's continuous service through such vesting date.
(5)	$1.19593
(6)	One fourth (1/4) of the shares subject to the option award vested on June 18, 2025 and the remaining shares subject to the option vested or shall vest in twelve (12) equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
(7)	One fourth (1/4) of the shares subject to the option award vested on February 27, 2026 and the remaining shares subject to the option vested or shall vest in twelve (12) equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
(8)	One fourth (1/4) of the shares subject to the option award shall vest on April 1, 2027 and the remaining shares subject to the option shall vest in twelve (12) equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.